We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 28 results
  1. Severe CSF immune cell alterations in cryptococcal meningitis gradually resolve during antifungal therapy

    Cryptococcal meningitis (CM) is a severe fungal disease in immunocompromised patients affecting the central nervous system (CNS). Host response and...

    Christine Dambietz, Michael Heming, ... Gerd Meyer zu Hörste in BMC Neurology
    Article Open access 03 July 2024
  2. Diagnostic yield of fluorescence-assisted frame-based stereotactic biopsies of intracerebral lesions in comparison with frozen-section analysis

    Purpose

    Stereotactic biopsies are routinely used to establish a histological diagnosis of unclear cerebral pathologies. Intraoperatively,...

    Vesna Malinova, Kajetan von Eckardstein, ... Veit Rohde in Journal of Neuro-Oncology
    Article 27 August 2020
  3. Generate-Boost: study protocol for a prospective, multicenter, randomized controlled, double-blinded phase II trial to evaluate efficacy and safety of bortezomib in patients with severe autoimmune encephalitis

    Background

    Autoimmune encephalitis is a new spectrum of autoimmune disorders of the central nervous system (CNS), which are characterized by...

    Jonathan Wickel, Ha-Yeun Chung, ... Christian Geis in Trials
    Article Open access 08 July 2020
  4. Disease reactivation after switching from natalizumab to daclizumab

    Discontinuation of natalizumab can lead to severe rebound of disease activity in patients with relapsing–remitting multiple sclerosis (RRMS);...

    Timo Uphaus, Christoph Oberwittler, ... Stefan Bittner in Journal of Neurology
    Article 03 October 2017
  5. The risk of infections in hematologic patients treated with rituximab is not influenced by cumulative rituximab dosage - a single center experience

    Background

    Rituximab, a monoclonal antibody directed against CD20, is approved for the treatment of CD20-positive B-cell Non-Hodgkin’s lymphoma and...

    Johanna C Nissen, Margit Hummel, ... Mark Reinwald in BMC Infectious Diseases
    Article Open access 03 July 2014
  6. Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066)

    Introduction

    There was a growing need for practical guidelines for the most common OIs in Germany and Austria under consideration of the local...

    J. Thoden, A. Potthoff, ... C. Hoffmann in Infection
    Article Open access 14 September 2013
  7. Severe leukoencephalopathy with fulminant cerebral edema reflecting immune reconstitution inflammatory syndrome during HIV infection: a case report

    Introduction

    Immune reconstitution inflammatory syndrome is a well-known complication in HIV-infected patients after initiation of highly active...

    Christian Oelschlaeger, Rainer Dziewas, ... Ingo W Husstedt in Journal of Medical Case Reports
    Article Open access 17 July 2010
  8. Immune reconstitution after haploidentical hematopoietic cell transplantation: impact of reduced intensity conditioning and CD3/CD19 depleted grafts

    Haploidentical hematopoietic cell transplantation (HHCT) using CD34 selected grafts is complicated by slow engraftment and immune reconstitution....

    B Federmann, M Hägele, ... W A Bethge in Leukemia
    Article 14 October 2010
  9. Encephalopathy, visual disturbance and hearing loss—recognizing the symptoms of Susac syndrome

    Background . A 23 year-old female presented to a neurology department with a 3 year history of recurrent episodes involving hearing loss,...

    Jan Dörr, Helena Radbruch, ... Friedemann Paul in Nature Reviews Neurology
    Article 01 December 2009
  10. Effective Treatment of Patients in a Deep Salvage Situation with "Non-Active HAART": Experiences with the Expert Advice System RADATA

    Background:

    Clinical studies suggest expert recommendations as a possibility to optimize highly active antiretroviral therapy (HAART) in patients with...

    T. Lorenzen, I. Walther, ... A. Plettenberg in Infection
    Article 13 October 2009
  11. Disease-Modifying Agents for Multiple Sclerosis

    Multiple sclerosis (MS) is a chronic autoimmune disease of the CNS. Currently, six medications are approved for immunmodulatory and immunosuppressive...

    Til Menge, Martin S. Weber, ... Olaf Stüve in Drugs
    Article 01 December 2008
  12. Hodgkins disease presenting with granulomatous angiitis of the central nervous system

    Niall Sheehy, Katherine Sheehan, ... Norman Delanty in Journal of Neurology
    Article 01 January 2003
Did you find what you were looking for? Share feedback.